Trial · NCT00624052
Registered outcomes14
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 14 of 14
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Trough Seated Diastolic Blood Pressure (DBP) Control | End of study (34 weeks or last value on treatment) | The number of patients who reached the target DBP of \<90mmHg |
| Secondary | Trough Seated Systolic Blood Pressure (SBP) Control | End of study (34 weeks or last value on treatment) | The number of patients who reached the target SBP of \>=140mmHg |
| Secondary | Change From Baseline to End of Study in Trough Seated Diastolic Blood Pressure | Baseline is defined as visit 3 of study NCT00553267 and end of study as 34 weeks or last value on treatment | Change from baseline to the end of study in trough DBP. Baseline is defined as visit 3 of trial 1235.6 |
| Secondary | Change in DBP From Last Available Trough in NCT00553267 to Last Available Trough in NCT00624052 | Last available trough in NCT00553267 to end of study (34 weeks or last value on treatment) | The difference between the last available troughs represents the additional reduction in DBP in this study |
| Secondary | Change From Baseline to End of Study in Trough Seated Systolic Blood Pressure | Baseline is defined as visit 3 of study NCT00553267 and end of study as 34 weeks or last value on treatment | Change from baseline to the end of study in trough SBP. Baseline is defined as visit 3 of trial 1235.6 |
| Secondary | Change in SBP From Last Available Trough in NCT00553267 to Last Available Trough in NCT00624052 | Last available trough in NCT00624052 to end of study (34 weeks or last value on treatment) | The difference between the last available troughs represents the additional reduction in SBP in this study |
| Secondary | Trough Seated DBP Response | End of study (34 weeks or last value on treatment) | The number of patients who reach the target DBP of \<90mmHg or had a reduction in DBP \>= 10mmHg |
| Secondary | Trough Seated SBP Response | End of study (34 weeks or last value on treatment) | The number of patients who reach the target SBP of \<140mmHg or had a reduction in SBP \>= 15 mmHg |
| Secondary | Trough BP Normality Classes | End of study (34 weeks or last value on treatment) | The number of patients who reach predefined BP categories |
| Secondary | Time to First Additional Antihypertensive | up to 34 weeks | Time from first intake of medication to first intake of an antihypertensive other than the study drug |
| Secondary | Number of Patients Requiring Additional Antihypertensive Therapy to Achieve DBP Control | up to 34 weeks | The number of patients with DBP control (DBP\>=90 mmHg). Last trough DBP measurement before taking additional antihypertensive compared to last trough DBP taken on treatment |
| Secondary | Additional Reduction in DBP by Use of Additional Antihypertensive Therapy | up to 34 weeks | Difference in trough DBP from last visit before add-on therapy and last visit during NCT00624052 |
| Secondary | Additional Reduction in SBP by Use of Additional Antihypertensive Therapy | up to 34 weeks | Difference in trough SBP from last visit before add-on therapy and last visit during NCT00624052 |
| Secondary | Trough DBP Control Pre- and Post- Uptitration | up to 34 weeks | The number of patients with DBP control (DBP\<90 mmHg). Last trough DBP measurement before uptitration to telmisartan 80mg and amlodipine 10mg compared to first trough DBP taken after uptitration. Uptitration could be based DBP\>90 or investigator opinion. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00624052/registered